Bronchogen (AEDL): Lung Bioregulator, Rat Data Only
Bronchogen is the Khavinson tetrapeptide Ala-Glu-Asp-Leu marketed for the bronchi. Evidence is rat COPD models and cell work from one group; no human trials.
Peptide Therapy
14 articles on Peptide Bioregulators by Dr. med. univ. Julian Douwes: Peptide Bioregulators: The Khavinson Protocol and What the Evidence Shows; and more.
Bronchogen is the Khavinson tetrapeptide Ala-Glu-Asp-Leu marketed for the bronchi. Evidence is rat COPD models and cell work from one group; no human trials.
Cardiogen (Ala-Glu-Asp-Arg) is a Khavinson tetrapeptide sold for the heart. Data are cell cultures and rat tumour studies from one group; no human trials.
Cartalax (Ala-Glu-Asp) is a Khavinson Cytogen marketed for cartilage and joints. Evidence is human cell cultures and rat kidney work; no osteoarthritis trials.
Cortagen (Ala-Glu-Asp-Pro) is a Khavinson brain-cortex tetrapeptide. Rat nerve-regeneration and ischaemia data exist; human evidence is an unpublished claim.
Crystagen (Glu-Asp-Pro) is a Khavinson Cytogen sold for the immune system. PubMed holds a few cell and docking studies, no human trials. What is known.
Livagen (Lys-Glu-Asp-Ala) is a Khavinson liver tetrapeptide. Data are test-tube chromatin studies in elderly lymphocytes and rat work; no human trials.
Ovagen (Glu-Asp-Leu) is a Khavinson Cytogen sold for liver and gut. Its PubMed studies are rat kidney and cell work. Not an ovary peptide. What the data show.
Pinealon (Glu-Asp-Arg) is a Khavinson tripeptide sold for the brain. Cell and mouse data plus one small uncontrolled human study. Evidence, dosing and reports.
Prostamax (Lys-Glu-Asp-Pro) is a Khavinson tetrapeptide sold for the prostate. Data are lymphocyte chromatin and rat tissue studies; no BPH or PSA trials.
Testagen (Lys-Glu-Asp-Gly) is sold as a testicular bioregulator, but its PubMed studies describe a pituitary-derived peptide tested in chickens. The evidence.
Thymogen (Glu-Trp, oglufanide) is a licensed immunostimulant in Russia. The same dipeptide failed a US phase III trial in Kaposi sarcoma. Evidence and doses.
Vesugen (Lys-Glu-Asp) is a Khavinson Cytogen sold for blood vessels. Endothelial cell data, Alzheimer mouse work and one small human study. What it shows.
Vilon (Lys-Glu) is a Khavinson thymus dipeptide. Mouse lifespan and tumour studies, cell data and one small diabetes study exist; no controlled human trials.
Dr. med. univ. Julian Douwes reviews Russian short-chain peptide bioregulators — Thymalin, Pinealon, Cortagen, Ventfort — and the Khavinson protocol's evidence for longevity.